Navigation Links
CorMatrix Receives FDA IDE Approval to Begin Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM™ for Pericardial Closure
Date:9/10/2010

ATLANTA, Sept. 10 /PRNewswire/ -- CorMatrix Cardiovascular, Inc., a medical device company developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that FDA has granted conditional approval for the start of a multi-center, prospective, randomized clinical trial to demonstrate the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation. Patients enrolled in the trial will undergo circumferential reconstruction of the normal pericardial anatomy following isolated, first-time, coronary artery bypass grafting (CABG) procedures and will be compared to subjects who do not undergo pericardial closure.

The clinical trial, anticipated to enroll more than 400 patients at up to 15 cardiac surgery sites in the United States, is being initiated by CorMatrix following analysis of data from a retrospective study that demonstrated a statistically significant reduction in the rate of new onset postoperative atrial fibrillation in CABG patients following pericardial closure with the CorMatrix ECM. Data from this retrospective study have been accepted and will soon be published in a peer-reviewed journal.

"We've heard anecdotally for some time that the use of CorMatrix ECM technology to reconstruct the native pericardial anatomy seems to reduce the risk for new onset postoperative atrial fibrillation," said Robert G. Matheny, M.D., Chief Scientific Officer, CorMatrix Cardiovascular. "Following a review of the retrospective data and the growing data on the incidence and significance of postoperative atrial fibrillation, we believe this is an important study to undertake."

Following cardiac surgery, new onset postoperative atrial fibrillation is the most common arrhythmic complication, with reported incidence between 32% and 64%, and poses a serious concern for patie
'/>"/>

SOURCE CorMatrix Cardiovascular, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CorMatrix(R) ECM(TM) Receives CE Mark for Cardiac Tissue Repair
2. CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue
3. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
4. Say Goodbye to Unwanted Love Handles: CoolSculpting by ZELTIQ™ Receives FDA Clearance for Patented, Non-Invasive Cooling Treatment for Fat Reduction
5. Watsons Generic Yasmin® Receives FDA Approval
6. Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
7. Celsion Receives SBIR Grant To Expand Its Technology Platform
8. Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System
9. K-V Pharmaceutical Company Receives Notification From New York Stock Exchange of Compliance With Quantitative Continued Listing Standards
10. Actavis Receives FDA Approval of Atomoxetine HCl Capsules
11. Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... DUBLIN , Aug. 31, 2015 Research ... of the "Regulatory Affairs for Support Staff (London, ... offering. This two day course provides ... of drug development and has been designed specifically for ... You will gain an overview of EU regulatory ...
(Date:9/1/2015)... , Sept. 1, 2015 Egalet Corporation ... specialty pharmaceutical company focused on discovering, developing, and ... will be  presenting scientific data on SPRIX ® ... extended-release, oral morphine product candidate, and Egalet-002, an ... PainWeek 2015 to be held September ...
(Date:9/1/2015)... 1, 2015  Abbott (NYSE: ABT ) announced today ... randomized trial comparing the safety and effectiveness of Abbott,s ... , Abbott,s market-leading, permanent drug eluting stent. The trial ... and enrolled 400 people with coronary artery ... results will be featured at a late-breaking session today ...
Breaking Medicine Technology:Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4
... InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the ... that it has been approved by FINRA to have its ... symbol "NSPR". In addition, on March 31, 2011, ... it raised approximately $9.0 million of cash and (ii) approximately ...
... ATLANTA, May 5, 2011 CardioMEMS, Inc ., ... is commercializing a proprietary wireless sensing and communication technology ... and CEO Jay Yadav, M.D., has been chosen as ... Awards. The awards are presented by the Atlanta Business ...
Cached Medicine Technology:InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 2InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 3InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 4InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR" 5CardioMEMS Founder Dr. Jay Yadav Chosen as Health-Care Heroes Finalist by Atlanta Business Chronicle 2
(Date:9/1/2015)... ... September 01, 2015 , ... An ... of thousands of plastic surgeries conducted each year on teenagers, quoting a New ... growing numbers. Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... explained how many dental practices across the country are switching from traditional dental ... to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora Dentistry Spa, his ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ( http://www.earthbrands.com ) ... Every customer who buys an Earth Brand shoe will be given an opportunity ... for the Future, a nonprofit dedicated to planting more trees. Earth Brands products ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... it Red for Lymphoma awareness initiative, the nation’s premier and most high-profile lymphoma ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary ... teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community College ... adult counselors, some of whom work for Calvary, and two junior counselors who were ...
Breaking Medicine News(10 mins):Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3
... Compounded Hormones, WASHINGTON, Feb. 12 ... called on the American,Association of Clinical Endocrinologists ... to fully disclose their financial ties to ... that directly benefits,the pharmaceutical giant. In recent ...
... 12 TeamStaff, Inc.,(Nasdaq: TSTF ) ... services, announced today that it is changing ... Staffing Services, Inc., to TeamStaff,Government Solutions (dba ... subsidiary currently provides medical, office,administration and logistics ...
... families may have underlying speech deficits , , TUESDAY, ... or family history of learning disabilities may be more ... causes them to lose language abilities as they age, ... known as primary progressive aphasia, causes language abilities to ...
... YUCAIPA, Calif., Feb. 12 Ingen Technologies,Inc. (OTC ... the signed distribution agreement with Progressive International,Holding Co. ... Taiwan, People,s,Republic of China, Japan and Korea. Please ... Progressive International Holding Company (PIHK),( http://www.pgiholding.com ) and ...
... announcement by,the United States Food and Drug Administration that ... toxin type A), customers are,looking for alternatives to treat ... in 2002 for the temporary treatment of,moderate to severe ... 65 years,of age. In its recent communication, the FDA ...
... Feb. 12 Iomai Corporation,(Nasdaq: IOMI ) today ... the second dose of the two-dose regimen for its ... when,self-applied by subjects outside of a clinical setting., ... program for the,vaccine, measured the immune response to the ...
Cached Medicine News:Health News:American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals 2Health News:TeamStaff Renames Subsidiary to Reflect Expanding Government Services 2Health News:TeamStaff Renames Subsidiary to Reflect Expanding Government Services 3Health News:Learning Disabilities May Presage Later Language Problems 2Health News:Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor 2Health News:Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor 3Health News:Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles 2Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 2Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 3Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: